About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Breast Cancer Tumor Care Observational Programme

NCT00660244·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

Any age

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Postmenopausal women
Already on upfront Arimidex Therapy (Start 1-4 weeks before)
HR+

You may not be if

Premenopausal women
Tamoxifen switch patients

The record

StatusCompleted

PhaseNo phase

Taking part150

StartedFeb 2008

UpdatedJun 6, 2012

Conditions

Post Menopausal Arthralgia

Where1

Research Site
Graz, Austria

Clareo Health | Breast Cancer Tumor Care Observational Programme